06.05.2020 Novavax Inc (NVAX) Daily Analysis

06.05.2020 Novavax Inc (NVAX) Daily Analysis

Novavax Inc (NVAX) 17.78 -0.28    -1.55% Shares of Novavax (NASDAQ:NVAX) went down by 1.55%  and today the stock is trading on 17.78USD. The company did not post any news inline with their vaccine or anything but what is making the stock go down is that Gilead Sciences announced their positive results from phase 3 clinical trial for Remdesivir and within a week The CEO and Chairman of Gilead Sciences announced on Sunday that their company is donating 1.5 million vials to the U.S  government of  Remdesivir to treat 150 000 to 200 000 patients that are suffering from the Covid -19 as the vaccine was now allowed to be used to treat patients. Remdesivir is the first vaccine that has been scientifically proven to assist in the treatment for COVID-19 and the medication will become available for U.S. hospitals this week. Investors right now are just focusing more on the vaccine that is on the heat since Novavax has not announced anything yet.